Exercise Intolerance and Rhabdomyolysis Due to Dystrophinopathy: A Pseudometabolic Presentation

Hayden Scott; Akilandeswari Aravindhan; Aravindhan Veerapandiyan

doi:10.1055/s-0041-1728693

Journal of Pediatric Neurology, Inhaltsverzeichnis

Journal of Pediatric Neurology 2022; 20(01): 080-082
DOI: 10.1055/s-0041-1728693

Letter to the Editor

Exercise Intolerance and Rhabdomyolysis Due to Dystrophinopathy: A Pseudometabolic Presentation

Hayden Scott

¹Division of Neurology, Department of Pediatrics, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

,

Akilandeswari Aravindhan

¹Division of Neurology, Department of Pediatrics, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

,

Aravindhan Veerapandiyan

¹Division of Neurology, Department of Pediatrics, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

References
1 Darras BT, Urion DK, Ghosh PS. Dystrophinopathies. 2000 Sep 5 [Updated 2018 Apr 26]. In: Adam MP, Ardinger HH, Pagon RA. et al., eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; ; 1993–2019. Accessed March 18, 2021 from: https://www.ncbi.nlm.nih.gov/books/NBK1119/
2 Harada Y, Sorensen ST, Aravindhan A. et al. Dystrophinopathy in a family due to a rare nonsense mutation causing predominant behavioral phenotype. J Pediatr Neurol 2020; 18 (04) 210-213
3 Veerapandiyan A, Shashi V, Jiang YH, Gallentine WB, Schoch K, Smith EC. Pseudometabolic presentation of dystrophinopathy due to a missense mutation. Muscle Nerve 2010; 42 (06) 975-979
4 Saylam E, Aravindhan A, Stefans V, Veerapandiyan A. Pseudometabolic presentation of dystrophinopathy in a family due to a rare nonsense mutation. J Clin Neuromuscul Dis 2020; 21 (04) 245-246
5 Cohen BH. Mitochondrial and metabolic myopathies. Continuum (Minneap Minn) 2019; 25 (06) 1732-1766
6 Baranzini SE, del Rey G, Nigro N, Szijan I, Chamoles N, Cresto JC. Patient with an Xp21 contiguous gene deletion syndrome in association with agenesis of the corpus callosum. Am J Med Genet 1997; 70 (03) 216-221
7 Upadhyayula S, Shellenbarger KC, Wong BL. GP5: Clinical profile of a 6-year-old boy with Becker Muscular Dystrophy and asymptomatic rhabdomyolysis: a case report. Neuromuscul Disord 2014; 24: 795